Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $105.26 USD
Change Today +0.84 / 0.80%
Volume 828.8K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleKey Developments
John Clarke 89 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Kevin Starr 88 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee 
Marsha Fanucci 60 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitle
Steven Paul M.D. 122 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Technology Committee
Paul Schimmel Ph.D. 92 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
Kevin Starr 88 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
ALNY Compensation vs. Industry
689.6K
320.7K
Chief Executive Officer
257.2K
230.8K
Chief Financial Officer
515.0K
293.9K
Chief Operating Officer
Share price activity for ALNYLAM PHARMACEUTICALS INC (ALNY)
52 Week Price Performance
ALNY
Industry Average

Nominating Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleKey Developments
John Clarke 89 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeLaurence Reid to Resign from Alnylam Pharmaceuticals, Inc. as Chief Business Officer, Effective December 31, 2014
12/19/14
Phillip Sharp Ph.D. 174 RelationshipsDirector, Member of The Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance CommitteeAlnylam Pharmaceuticals, Inc. Elects Michael W. Bonney to its Board of Directors
12/18/14
Dennis Ausiello M.D. 96 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Nominating & Corporate Governance Committee and Member of Science & Technology CommitteeAlnylam Pharmaceuticals, Inc. Appoints Pushkal Garg as Senior Vice President, Clinical Development
10/29/14
Marsha Fanucci 60 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeAlnylam Pharmaceuticals, Inc. Announces New Appointments
09/15/14
Amy Schulman J.D. 132 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeAlnylam Pharmaceuticals, Inc. Elects Amy W. Schulman as Class III Director
07/2/14

Corporate Governance Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitle
Dennis Ausiello M.D. 96 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Technology Committee
John Clarke 89 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
Marsha Fanucci 60 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Amy Schulman J.D. 132 Relationships--
Phillip Sharp Ph.D. 174 Relationships--
ALNY and Competitor
Insiders vs. External
Board
12%
88%
Alnylam Pharmaceuticals, Inc.
31%
69%
Silence Therapeutics plc
0%
100%
Enzon Pharmaceuticals Inc.
8%
92%
Galena Biopharma, Inc.
29%
71%
Tekmira Pharmaceuticals Corporation
8%
92%
Regulus Therapeutics Inc.
Insiders
External Board Members

Advisory Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Board Relationships)/Title Board Affiliations
Dennis Ausiello 96 Relationships
Director, Member of the Scientific Advisory Board, Member of Nominating & Corporate Governance Committee and Member of Science & Technology Committee
No other board affiliations
David Bartel 28 Relationships
Member of Scientific Advisory Board
No other board affiliations
Judy Lieberman 24 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Rader 47 Relationships
Member of Scientific Advisory Board
No other board affiliations
Paul Schimmel 92 Relationships
Director, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
No other board affiliations
Phillip Sharp 174 Relationships
Director, Member of The Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee
No other board affiliations
Markus Stoffel 26 Relationships
Member of Scientific Advisory Board
No other board affiliations
Thomas Tuschl 25 Relationships
Member of Scientific Advisory Board
No other board affiliations
Phillip Zamore 16 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $105.26 USD +0.84

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzon Pharmaceuticals Inc $1.09 USD +0.03
Galena Biopharma Inc $1.37 USD -0.02
Regulus Therapeutics Inc $17.45 USD +0.51
Silence Therapeutics PLC 280.00 GBp -5.62
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 158.9x
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 159.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.